HighLife

Description: Paris-based HighLife develops a transcatheter mitral valve replacement system to treat mitral regurgitation, currently in clinical trials.

Country: France

Based in: Paris

Founded: 2010

Funding Stage: Series A/B

Tags: ['MedTech', 'Heart Disease', 'Healthcare', 'Medical Devices']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.